Want to join the conversation?
Imaging and analytics services provider $XRX delivered substantial EPS growth in 2Q16. Adjusted EPS was above guidance and $XRX saw margin expansion in both its business segments, putting the company on track to achieve its full-year 2016 guidance.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?